EBF3 reactivation by inhibiting the EGR1/EZH2/HDAC9 complex promotes metastasis via transcriptionally enhancing vimentin in nasopharyngeal carcinoma
Open Access
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 527, 49-65
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast CancersMolecular Cell, 2011
- Long Term Transcriptional Reactivation of Epigenetically Silenced Genes in Colorectal Cancer Cells Requires DNA Hypomethylation and Histone AcetylationPLOS ONE, 2011
- Emerging Roles of the EBF Family of Transcription Factors in Tumor SuppressionMolecular Cancer Research, 2009
- Disruption of Transforming Growth Factor-β Signaling by Five Frequently Methylated Genes Leads to Head and Neck Squamous Cell Carcinoma PathogenesisCancer Research, 2009
- The ‘zinc knuckle’ motif of Early B cell Factor is required for transcriptional activation of B cell-specific genesMolecular Immunology, 2008
- An EBF3-Mediated Transcriptional Program That Induces Cell Cycle Arrest and ApoptosisCancer Research, 2006
- EBF2 Regulates Osteoblast-Dependent Differentiation of OsteoclastsDevelopmental Cell, 2005
- Early B-cell factor ‘pioneers’ the way for B-cell developmentTrends in Immunology, 2005
- Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumorsNature Genetics, 2002
- Cloning of a Novel Olf-1/EBF-like Gene, O/E-4, by Degenerate Oligo-based Direct SelectionMolecular and Cellular Neuroscience, 2002